Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:35:09 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:PHAR from 2023-04-26 to 2024-04-25 - 20 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-24 01:00U:PHARNews ReleasePharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD(TM)) 2024 Rare Impact Awards
2024-04-08 01:00U:PHARNews ReleasePharming announces completion of enrollment in pediatric clinical trial of leniolisib
2024-04-03 02:00U:PHARNews ReleasePharming Group to participate in April investor conferences
2024-03-14 02:00U:PHARNews ReleasePharming Group reports fourth quarter and full year 2023 financial results
2024-02-29 02:00U:PHARNews ReleasePharming Group to report fourth quarter and full year 2023 financial results on March 14
2024-02-08 02:00U:PHARNews ReleasePharming Group to participate in February investor conferences
2024-01-08 01:00U:PHARNews ReleasePharming Group announces updated full year 2023 guidance and Joenja ‚ ® U.S. launch update
2023-12-13 01:00U:PHARNews ReleasePharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)
2023-11-21 01:00U:PHARNews ReleasePharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
2023-11-01 03:00U:PHARNews ReleasePharming Group to participate in November investor conferences
2023-10-26 01:00U:PHARNews ReleasePharming Group reports third quarter 2023 financial results
2023-10-12 02:00U:PHARNews ReleasePharming Group to report third quarter 2023 financial results on October 26
2023-09-25 10:00U:PHARNews ReleasePharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
2023-08-24 02:00U:PHARNews ReleasePharming Group to participate in September investor conferences
2023-08-09 01:00U:PHARNews ReleasePharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
2023-07-18 01:00U:PHARNews ReleasePharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board
2023-07-13 02:00U:PHARNews ReleasePharming Group to report second quarter and first half 2023 financial results on August 3
2023-06-01 01:00U:PHARNews ReleasePharming announces sale of priority review voucher
2023-05-25 02:00U:PHARNews ReleasePharming Group to attend the following Investor Conferences in June
2023-05-11 01:00U:PHARNews ReleasePharming Group reports financial results for the first quarter of 2023